Biobot Surgical

Private

SingaporeHealthcare & Life Scienceshttps://biobotsurgical.com/

Last Round

VC Round

Jun 29, 2026

Total Funding Raised

$18M

Company Overview

Biobot Surgical is a healthcare technology company that develops robotic-assisted surgical systems for minimally invasive prostate biopsies and targeted treatments.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

robotic-assisted surgeryprostate biopsyurology roboticsrobot-assisted urologyimage-guided surgerytransperineal biopsyMRI-ultrasound fusionsurgical roboticsmedical deviceprostate cancer diagnosticssurgical navigationmedical imagingsurgical automationrobot-assisted surgerymedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biobot Surgical Comps

Public and private peers based on sector, stage, and business model.

Biobot Surgical comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Biobot Surgical Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Jun 29, 2026
Series B	Mar 7, 2024
VC Round	Nov 7, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

CHEN HONGJUN

Chief Technology Officer

Executive Team

Biobot Surgical Investors

Notable investors and investment history

Biobot Surgical investors
Investor	Rounds
ClavystBio	VC Round
ZIG Ventures	VC Round, Series B

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 7, 2024
$18M round led by Tony Tan Choon Keat.

View all signals

Biobot Surgical Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Biobot Surgical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biobot Surgical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore

Employee Range40

Year Founded2009

Last FundingJun 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.